Literature DB >> 16887331

Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line.

Tomo Yonezawa1, Yosuke Kobayashi, Yoshiaki Obara.   

Abstract

The expression of GPR41 and 43, which have recently been identified as G-protein-coupled cell-surface receptors for short-chain fatty acids (SCFAs), was detected in a human breast cancer cell line (MCF-7) by RT-PCR. Acetate, propionate and butyrate induced an increase in intracellular Ca2+ in these cells that was not blocked by treatment with pertussis toxin (PTX). SCFAs significantly reduced forskolin-induced cAMP levels in these cells. The phosphorylation of mitogen-activated protein kinase (MAPK) p38 was selectively increased by SCFAs. The downstream substrate heat shock protein 27 (HSP27) was also phosphorylated by SCFAs at Ser-78 and-82, but not-15. Propionate induced elevations in intracellular Ca2+ and the phosphorylation of p38 were inhibited by the silencing of GPR43 using a specific siRNA. These results suggest that GPR41 and 43 mediate SCFA signaling in mammary epithelial cells and thereby play an important role in their stress management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887331     DOI: 10.1016/j.cellsig.2006.06.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  25 in total

Review 1.  Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Authors:  Medha Priyadarshini; Kumar U Kotlo; Pradeep K Dudeja; Brian T Layden
Journal:  Compr Physiol       Date:  2018-06-18       Impact factor: 9.090

Review 2.  From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology.

Authors:  Niranjana Natarajan; Jennifer L Pluznick
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-01       Impact factor: 4.249

Review 3.  The therapeutic potential of GPR43: a novel role in modulating metabolic health.

Authors:  Lauren M Cornall; Michael L Mathai; Deanne H Hryciw; Andrew J McAinch
Journal:  Cell Mol Life Sci       Date:  2013-07-14       Impact factor: 9.261

4.  Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.

Authors:  Pan Pan; Chad W Skaer; Hsin-Tzu Wang; Kiyoko Oshima; Yi-Wen Huang; Jianhua Yu; Jianying Zhang; Martha M Yearsley; Kimberle A Agle; William R Drobyski; Xiao Chen; Li-Shu Wang
Journal:  Carcinogenesis       Date:  2016-11-19       Impact factor: 4.944

Review 5.  Diet, gut microbiome, and bone health.

Authors:  Connie M Weaver
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

Review 6.  Probiotics Treatment of Leg Diseases in Broiler Chickens: a Review.

Authors:  Tingting Xu; Ke Yue; Chaodong Zhang; Xishuai Tong; Luxi Lin; Qinqin Cao; Shucheng Huang
Journal:  Probiotics Antimicrob Proteins       Date:  2021-11-10       Impact factor: 4.609

7.  Expression of the short-chain fatty acid receptor, GPR43, in the human colon.

Authors:  Shin-Ichiro Karaki; Hideaki Tazoe; Hisayoshi Hayashi; Hidefumi Kashiwabara; Kazunari Tooyama; Yuichi Suzuki; Atsukazu Kuwahara
Journal:  J Mol Histol       Date:  2007-09-27       Impact factor: 2.611

8.  Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase.

Authors:  E Lecona; J I Barrasa; N Olmo; B Llorente; J Turnay; M A Lizarbe
Journal:  Mol Cell Biol       Date:  2008-06-09       Impact factor: 4.272

9.  Microbial metabolites, short-chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice.

Authors:  Myunghoo Kim; Leon Friesen; Jeongho Park; Hyungjin M Kim; Chang H Kim
Journal:  Eur J Immunol       Date:  2018-05-17       Impact factor: 5.532

Review 10.  The metabolic fate of acetate in cancer.

Authors:  Zachary T Schug; Johan Vande Voorde; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.